Log in
Enquire now
Phase Genomics

Phase Genomics

Phase Genomics is an American biotechnology company.

OverviewStructured DataIssuesContributors
Is a
Company
Company
Organization
Organization
B2X
B2B2C
B2B2C
CEO
Ivan Liachko
Ivan Liachko
CIK Number
1,722,760
Legal Name
Phase Genomics, Inc.
Company Operating Status
Active
Competitors
Eagle Genomics
Eagle Genomics
Country
United States
United States
Crunchbase URL
crunchbase.com/organiz...genomics
Date Incorporated
2015
DUNS Number
079752735
Facebook URL
@phasegenomics
Founder
Ivan Liachko
Ivan Liachko
Maitreya Dunham
Maitreya Dunham
Jay Shendure
Jay Shendure
Shawn Sullivan
Shawn Sullivan
Full Address
4000 MASON ROAD, SUITE 225, SEATTLE, WA, 98195
Industry
Engineering
Engineering
Genetics
Genetics
Genomics
Genomics
Biomedical engineering
Biomedical engineering
Investors
Congruent Ventures
Congruent Ventures
WRF Capital
WRF Capital
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation
National Institute of Allergy and Infectious Diseases
National Institute of Allergy and Infectious Diseases
Latest Funding Round Date
February 2021
Latest Funding Type
Seed
Seed
Legal classification
Corporation
Corporation
LinkedIn URL
@company/phase-genomics-inc
Location
Seattle
Seattle
Number of Employees (Ranges)
11 – 50
Patents Assigned (Count)
1
Total Funding Amount (USD)
9,800,000
Twitter URL
@phasegenomics
Official Website
phasegenomics.com
YouTube Channel
youtube.com/channel/U...HrAbGi9uNA

Find more companies like Phase Genomics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.